Tag: enzalutamide

650×450 QD ASCO 2019
June 25, 2019/Cancer/Research

These Are the ASCO 2019 Abstracts That Will Make a Difference

Cleveland Clinic Cancer Center staff selects the conference's most significant research

650×450-Prostate-Cancer-DNA-Precision-Medicine
November 21, 2017/Cancer

Precision Medicine Principles Applied to Prostate Cancer

Milestone studies advance understanding and treatment of prostate cancer

650×450-Sharifi
October 16, 2017/Cancer

Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment

One step closer to identifying patients predisposed to treatment-resistant prostate cancer

BackPage 1 of 1Next
Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad